Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from human gastric juice proteins
Medicare Part D Gross Spending on GLP-1s Increased Five-Fold Between 2019 and 2024, But Estimated Rebates of Around 50% Mean That Net Spending is Much Lower Gross Medicare Part D spending on GLP-1s in 2024 (not accounting for rebates) totaled $27.5 billion, a five-fold increase from 2019, reflecting an expansion in use of GLP-1s with more recent FDA approvals for type 2 diabetes
For patients requiring additional glycemic lowering, the dose can be further up-titrated to 14 mg once daily after taking the 7 mg dose for at least 30 days
New Jersey, despite its high insurance costs, actually has some of the better structural conditions for telehealth GLP-1 access thanks to full NP practice authority and a competitive insurance market among large employers
This is how you can introduce your patient to GLP-1 therapy, integrating it thoughtfully into a comprehensive weight management plan for safe and sustainable results
For safety and effectiveness, each injection should be given with a new, sterile needle
US$ 23.56
US$ 27.49
US$ 26.56
US$ 20.81
